Related Experiment Video
Updated: Feb 16, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
The biology and therapeutic management of melanoma brain metastases
Daniel Abate-Daga1, Maria C Ramello1, Inna Smalley2
1The Department of Immunology, The Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL, United States.
Abstract:
The recent years have seen significant progress in the development of systemic therapies to treat patients with advanced melanoma. Use of these new treatment modalities, which include immune checkpoint inhibitors and small molecule BRAF inhibitors, lead to increased overall survival and better outcomes. Although revolutionary, these therapies are often less effective against melanoma brain metastases, and frequently the CNS is the major site of treatment failure. The development of brain metastases remains a serious complication of advanced melanoma that is associated with significant morbidity and mortality. New approaches to both prevent the development of brain metastases and treat established disease are urgently needed. In this review we will outline the mechanisms underlying the development of melanoma brain metastases and will discuss how new insights into metastasis biology are driving the development of new therapeutic strategies. Finally, we will describe the latest data from the ongoing clinical trials for patients with melanoma brain metastases.
Insights
Systemic therapies improve advanced melanoma survival but often fail against brain metastases. New strategies targeting melanoma metastasis biology are crucial for better patient outcomes.
Area of Science:
- Oncology
- Neuro-oncology
- Melanoma Research
Background:
- Advanced melanoma treatment has advanced with immune checkpoint inhibitors and BRAF inhibitors, improving survival.
- However, these therapies show limited efficacy against melanoma brain metastases, a common cause of treatment failure.
- Melanoma brain metastases significantly increase morbidity and mortality, necessitating novel therapeutic approaches.
Purpose of the Study:
- To review the mechanisms driving melanoma brain metastasis development.
- To discuss how understanding metastasis biology informs new therapeutic strategies.
- To present current clinical trial data for melanoma brain metastases.
Main Methods:
- Literature review of melanoma brain metastasis mechanisms.
- Analysis of recent systemic therapy advancements.
- Summary of ongoing clinical trials for CNS melanoma.
Main Results:
- Systemic therapies offer survival benefits but CNS penetration remains a challenge.
- Melanoma brain metastases represent a critical unmet need in advanced disease.
- Emerging therapeutic strategies are being investigated based on metastasis biology.
Conclusions:
- Further research into melanoma brain metastasis is essential.
- Development of targeted therapies and preventative strategies is urgently required.
- Clinical trials are evaluating novel treatments for improved patient outcomes.
Related Concept Videos
What is Conservation Biology?
Therapeutic Index
Biological Effects of Radiation
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

